Pyogenic liver abscess medical therapy: Difference between revisions

Jump to navigation Jump to search
m (Bot: Removing from Primary care)
 
(5 intermediate revisions by 2 users not shown)
Line 4: Line 4:


==Overview==
==Overview==
Treatment of pyogenic liver abscess include non-surgical treatment and open surgical drainage. Non-surgical treatment treatment includes conservative management with [[antibiotics]] alone and [[percutaneous]] drainage.<ref name="pmid21206721">{{cite journal| author=Malik AA, Bari SU, Rouf KA, Wani KA| title=Pyogenic liver abscess: Changing patterns in approach. | journal=World J Gastrointest Surg | year= 2010 | volume= 2 | issue= 12 | pages= 395-401 | pmid=21206721 | doi=10.4240/wjgs.v2.i12.395 | pmc=3014521 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21206721  }} </ref>
Treatment of pyogenic liver abscess include non-surgical treatment and open surgical drainage. Non-surgical treatment includes conservative management with [[antibiotics]] alone and [[percutaneous]] drainage.<ref name="pmid21206721">{{cite journal| author=Malik AA, Bari SU, Rouf KA, Wani KA| title=Pyogenic liver abscess: Changing patterns in approach. | journal=World J Gastrointest Surg | year= 2010 | volume= 2 | issue= 12 | pages= 395-401 | pmid=21206721 | doi=10.4240/wjgs.v2.i12.395 | pmc=3014521 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21206721  }} </ref>


==Treatment==
==Treatment==
*Antibiotic therapy is the initial treatment of choice followed by percutaneous drainage. If the abscess does not improve on medical therapy or failure to perform percutaneous drainage, open surgical drainage is performed.
*[[Antibiotic therapy]] is the initial treatment of choice followed by [[percutaneous]] drainage. If the abscess does not improve on medical therapy or failure to perform percutaneous drainage, open surgical drainage is performed.
*Treatment of pyogenic liver abscess include:<ref name="pmid21206721">{{cite journal| author=Malik AA, Bari SU, Rouf KA, Wani KA| title=Pyogenic liver abscess: Changing patterns in approach. | journal=World J Gastrointest Surg | year= 2010 | volume= 2 | issue= 12 | pages= 395-401 | pmid=21206721 | doi=10.4240/wjgs.v2.i12.395 | pmc=3014521 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21206721  }} </ref>
*Treatment of pyogenic liver abscess include:<ref name="pmid21206721">{{cite journal| author=Malik AA, Bari SU, Rouf KA, Wani KA| title=Pyogenic liver abscess: Changing patterns in approach. | journal=World J Gastrointest Surg | year= 2010 | volume= 2 | issue= 12 | pages= 395-401 | pmid=21206721 | doi=10.4240/wjgs.v2.i12.395 | pmc=3014521 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21206721  }} </ref>
{{Family tree/start}}
{{Family tree/start}}
Line 14: Line 14:
{{Family tree | | | B01 | | | | B02|B01=Non-surgical treatment|B02= Open surgical drainage}}
{{Family tree | | | B01 | | | | B02|B01=Non-surgical treatment|B02= Open surgical drainage}}
{{family tree | |,|-|^|-|.|}}
{{family tree | |,|-|^|-|.|}}
{{family tree | C01 | | C02|C01=Conservative management with antibiotics alone|C02=Percutaneous drainage}}
{{family tree | C01 | | C02|C01=Conservative management with [[antibiotics]] alone|C02=[[Percutaneous]] drainage}}
{{Family tree/end}}
{{Family tree/end}}


==Medical Therapy==
==Medical Therapy==
Empiric [[antibiotic]] therapy based on culture and sensitivity include:<ref name="pmid12380791">{{cite journal| author=Chen YW, Chen YS, Lee SS, Yen MY, Wann SR, Lin HH et al.| title=A pilot study of oral fleroxacin once daily compared with conventional therapy in patients with pyogenic liver abscess. | journal=J Microbiol Immunol Infect | year= 2002 | volume= 35 | issue= 3 | pages= 179-83 | pmid=12380791 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=12380791  }} </ref><ref name="pmid15057896">{{cite journal| author=Yu SC, Ho SS, Lau WY, Yeung DT, Yuen EH, Lee PS et al.| title=Treatment of pyogenic liver abscess: prospective randomized comparison of catheter drainage and needle aspiration. | journal=Hepatology | year= 2004 | volume= 39 | issue= 4 | pages= 932-8 | pmid=15057896 | doi=10.1002/hep.20133 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15057896  }} </ref>
Empiric [[antibiotic]] therapy based on [[Culture medium|culture]] and sensitivity include:<ref name="pmid12380791">{{cite journal| author=Chen YW, Chen YS, Lee SS, Yen MY, Wann SR, Lin HH et al.| title=A pilot study of oral fleroxacin once daily compared with conventional therapy in patients with pyogenic liver abscess. | journal=J Microbiol Immunol Infect | year= 2002 | volume= 35 | issue= 3 | pages= 179-83 | pmid=12380791 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=12380791  }} </ref><ref name="pmid15057896">{{cite journal| author=Yu SC, Ho SS, Lau WY, Yeung DT, Yuen EH, Lee PS et al.| title=Treatment of pyogenic liver abscess: prospective randomized comparison of catheter drainage and needle aspiration. | journal=Hepatology | year= 2004 | volume= 39 | issue= 4 | pages= 932-8 | pmid=15057896 | doi=10.1002/hep.20133 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15057896  }} </ref>


'''First choice'''
'''First choice'''


*1.Monotherapy
*1.[[Monotherapy]]
:*Preferred regimen(1):[[Ampicillin]]-[[sulbactam]] 3 g IV every six hours
:*Preferred regimen(1):[[Ampicillin]]-[[sulbactam]] 3 g IV every six hours
:*Preferred regimen(2):[[Piperacillin]]-[[tazobactam]] 3.375 or 4.5 g IV every six hours
:*Preferred regimen(2):[[Piperacillin]]-[[tazobactam]] 3.375 or 4.5 g IV every six hours
:*Preferred regimen(3):[[Ticarcillin]]-[[clavulanate]] 3.1 g IV every four hours
:*Preferred regimen(3):[[Ticarcillin]]-[[clavulanate]] 3.1 g IV every four hours
*2.Combination therapy
*2.[[Combination therapy]]
:*Preferred regimen(1):[[Ceftriaxone]] 1 g IV every 24 hours or 2 g IV every 12 hours for [[CNS]] [[infection]] '''plus''' [[Metronidazole]] 500 mg IV every eight hours
:*Preferred regimen(1):[[Ceftriaxone]] 1 g IV every 24 hours or 2 g IV every 12 hours for [[CNS]] [[infection]] '''plus''' [[Metronidazole]] 500 mg IV every eight hours


'''Alternative Emperic Regimens'''
'''Alternative Emperic Regimens'''
*1.Combination therapy [[fluoroquinolone]] PLUS [[metronidazole]]
*1.[[Monotherapy]]
:*Preferred regimen(1):[[Ciprofloxacin]] 400 mg IV every 12 hours '''or''' [[Levofloxacin]] 500 or 750 mg IV once daily '''Plus''' [[Metronidazole]] 500 mg IV every eight hours
*2.Monotherapy
:*Preferred regimen(1):[[Imipenem]]-[[cilastatin]] 500 mg IV every six hours
:*Preferred regimen(1):[[Imipenem]]-[[cilastatin]] 500 mg IV every six hours
:*Preferred regimen(2):[[Meropenem]] 1 g IV every eight hours
:*Preferred regimen(2):[[Meropenem]] 1 g IV every eight hours
:*Preferred regimen(3):[[Doripenem]] 500 mg IV every eight hours
:*Preferred regimen(3):[[Doripenem]] 500 mg IV every eight hours
:*Preferred regimen(4):[[Ertapenem]] 1 g IV once daily
:*Preferred regimen(4):[[Ertapenem]] 1 g IV once daily
*2.[[Combination therapy]]
:*[[Fluoroquinolone]] PLUS [[metronidazole]]
:*Preferred regimen(1):[[Ciprofloxacin]] 400 mg IV every 12 hours '''or''' [[Levofloxacin]] 500 or 750 mg IV once daily '''Plus''' [[Metronidazole]] 500 mg IV every eight hours
:


==References==
==References==
{{reflist|2}}
{{reflist|2}}
[[Category:Emergency mdicine]]
[[Category:Disease]]
[[Category:Up-To-Date]]
[[Category:Infectious disease]]
[[Category:Gastroenterology]]
[[Category:Hepatology]]

Latest revision as of 23:55, 29 July 2020

Liver abscess Main Page

Pyogenic liver abscess Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating pyogenic liver abscess from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Pyogenic liver abscess medical therapy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Pyogenic liver abscess medical therapy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Pyogenic liver abscess medical therapy

CDC on Pyogenic liver abscess medical therapy

Pyogenic liver abscess medical therapy in the news

Blogs on Pyogenic liver abscess medical therapy

Directions to Hospitals Treating Type chapter name here

Risk calculators and risk factors for Pyogenic liver abscess medical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Yamuna Kondapally, M.B.B.S[2]

Overview

Treatment of pyogenic liver abscess include non-surgical treatment and open surgical drainage. Non-surgical treatment includes conservative management with antibiotics alone and percutaneous drainage.[1]

Treatment

  • Antibiotic therapy is the initial treatment of choice followed by percutaneous drainage. If the abscess does not improve on medical therapy or failure to perform percutaneous drainage, open surgical drainage is performed.
  • Treatment of pyogenic liver abscess include:[1]
 
 
 
 
 
Treatment
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Non-surgical treatment
 
 
 
Open surgical drainage
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Conservative management with antibiotics alone
 
Percutaneous drainage

Medical Therapy

Empiric antibiotic therapy based on culture and sensitivity include:[2][3]

First choice

Alternative Emperic Regimens

  • Preferred regimen(1):Imipenem-cilastatin 500 mg IV every six hours
  • Preferred regimen(2):Meropenem 1 g IV every eight hours
  • Preferred regimen(3):Doripenem 500 mg IV every eight hours
  • Preferred regimen(4):Ertapenem 1 g IV once daily

References

  1. 1.0 1.1 Malik AA, Bari SU, Rouf KA, Wani KA (2010). "Pyogenic liver abscess: Changing patterns in approach". World J Gastrointest Surg. 2 (12): 395–401. doi:10.4240/wjgs.v2.i12.395. PMC 3014521. PMID 21206721.
  2. Chen YW, Chen YS, Lee SS, Yen MY, Wann SR, Lin HH; et al. (2002). "A pilot study of oral fleroxacin once daily compared with conventional therapy in patients with pyogenic liver abscess". J Microbiol Immunol Infect. 35 (3): 179–83. PMID 12380791.
  3. Yu SC, Ho SS, Lau WY, Yeung DT, Yuen EH, Lee PS; et al. (2004). "Treatment of pyogenic liver abscess: prospective randomized comparison of catheter drainage and needle aspiration". Hepatology. 39 (4): 932–8. doi:10.1002/hep.20133. PMID 15057896.